000 04192nam a22004215i 4500
999 _c106884
_d106884
001 106884
003 ESmaUEC
005 20240413095637.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 180709s2018 gw | s |||| 0|eng d
020 _a9783319637396
024 7 _a10.1007/978-3-319-63739-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
050 4 _aQP572.O9
_b2018 EB
245 0 0 _aBehavioral Pharmacology of Neuropeptides :
_bOxytocin
_cedited by Rene Hurlemann, Valery Grinevich
264 1 _aCham
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (IX, 593 páginas)
_b130 ilustraciones, 30 ilustraciones a color
336 _aTexto
_btxt
_2rdacontent
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 0 _aCurrent Topics in Behavioral Neurosciences
_x1866-3370
_v35
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aPreface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.
520 3 _aThis volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
650 7 _aOxitocina
_9667663
_2embne
700 1 _aHurlemann, Rene
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/n2018187623
700 1 _aGrinevich, Valery
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_9106996
776 0 8 _iPrinted edition:
_z9783319637389
776 0 8 _iPrinted edition:
_z9783319637402
776 0 8 _iPrinted edition:
_z9783030097035
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-63739-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
988 _aEBSPRINGER_BIOMEDLIFE_2019
998 _aSI
_a_alco
_a_vill
_b01/2019
_cm
_dz
_ef
_feng
_ggw
_h0